Log in

Aurora Cannabis Stock Forecast, Price & News

-0.15 (-2.88 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $5.05
50-Day Range
MA: $8.69
52-Week Range
Now: $5.05
Volume9.45 million shs
Average Volume5.81 million shs
Market Capitalization$582.96 million
P/E RatioN/A
Dividend YieldN/A
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.52 out of 5 stars

Industry, Sector and Symbol

Industry Medicinals & botanicals



Sales & Book Value

Annual Sales$215.10 million
Book Value$39.12 per share


Net Income$-219,670,000.00
Net Margins-442.62%


Market Cap$582.96 million
Next Earnings Date11/12/2020 (Estimated)
-0.15 (-2.88 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

How has Aurora Cannabis' stock been impacted by Coronavirus (COVID-19)?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ACB shares have decreased by 51.0% and is now trading at $5.05.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Aurora Cannabis?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 3 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Aurora Cannabis

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc (NYSE:ACB) posted its earnings results on Thursday, November, 14th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.36) by $0.48. The company had revenue of $57.02 million for the quarter, compared to analyst estimates of $72.82 million. Aurora Cannabis had a negative return on equity of 8.55% and a negative net margin of 442.62%.
View Aurora Cannabis' earnings history

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Shares of Aurora Cannabis reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What guidance has Aurora Cannabis issued on next quarter's earnings?

Aurora Cannabis updated its first quarter 2021 After-Hours earnings guidance on Tuesday, September, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $43.278-46.163 million.

What price target have analysts set for ACB?

17 analysts have issued 1 year target prices for Aurora Cannabis' shares. Their forecasts range from $8.00 to $24.00. On average, they expect Aurora Cannabis' stock price to reach $14.03 in the next twelve months. This suggests a possible upside of 177.9% from the stock's current price.
View analysts' price targets for Aurora Cannabis

Are investors shorting Aurora Cannabis?

Aurora Cannabis saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 23,380,000 shares, an increase of 18.6% from the August 31st total of 19,710,000 shares. Based on an average daily trading volume, of 4,330,000 shares, the days-to-cover ratio is presently 5.4 days. Approximately 20.9% of the company's shares are sold short.
View Aurora Cannabis' Short Interest

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), NVIDIA (NVDA), HEXO (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and KushCo (KSHB).

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 54)
  • Mr. Terry Booth, Founder, CEO & Director (Age 54)
  • Mr. Stephen Dobler, Founder, Pres & Director (Age 54)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (2.57%), Think Investments LP (0.54%), TD Asset Management Inc. (0.29%), Swiss National Bank (0.21%), Bank of America Corp DE (0.21%) and UBS Group AG (0.09%).

Which institutional investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Swiss National Bank, TD Asset Management Inc., Goldman Sachs Group Inc., Bank of America Corp DE, CIBC Asset Management Inc, State of Wisconsin Investment Board, and Commonwealth Equity Services LLC.

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was purchased by a variety of institutional investors in the last quarter, including Think Investments LP, Virtu Financial LLC, Kessler Investment Group LLC, Berman Capital Advisors LLC, Harbor Advisors LLC, and Captrust Financial Advisors.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $5.05.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of $582.96 million and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($2.64) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.